A profile of gout patients in Sarawak

被引:2
|
作者
Teh, C. L. [1 ]
Cheong, Y. K. [1 ]
Ling, H. N. [1 ]
Chan, P. L. [1 ]
Chan, T. [2 ]
Ling, G. R. [1 ]
机构
[1] Jalan Hosp, Sarawak Gen Hosp, Dept Med, Rheumatol Unit, Sarawak 93450, Malaysia
[2] Univ Liverpool, Liverpool L69 3BX, Merseyside, England
关键词
Gout; Tophi; Hospitalizations; EPIDEMIOLOGY; POPULATION; PREVALENCE;
D O I
10.1007/s00296-011-2245-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We performed a prospective study of all patients diagnosed with gout and who received treatment in Sarawak General Hospital from 1 July 2010 to 31 December 2010. There was a total of 138 patients in our study of which 92 (66.7%) were from the indigenous populations. They have a mean age of 56.5 +/- A 12.5 years with a mean duration of illness of 11.6 +/- A 8.7 years. The mean lag time between symptom onset to the diagnosis of gout was 2.8 +/- A 4.8 years and a mean lag time to appropriate treatment of gout of 8.8 +/- A 8.4 years. Sixty-six (47.8%) patients have family history of gout. The common complications of gout in our patients were tophi (47.1%), joint deformities (39.1%), kidney stones (16.7%), and uric acid nephropathy (0.7%). Hospitalization occurred in 93 (67.4%) patients. Gout is a serious medical problem in our centre. Gout affects middle-aged men, especially the indigenous populations. Almost half of our patients have a family history of gout and have tophi formations. Our gout patients have a significant delay in diagnosis and appropriate treatment, thus contributing to more complications and hospitalizations in our centre. There is an urgent need to educate both patients and healthcare workers on gout and its treatment to reduce the burden of chronic gout in Sarawak.
引用
收藏
页码:1079 / 1082
页数:4
相关论文
共 50 条
  • [21] Oxaprozin in patients with gout
    Monov, Simeon
    Monova, Daniela
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2009, 27 (05) : 739 - 739
  • [22] OSTEOPOROSIS IN PATIENTS WITH GOUT
    Rotaru, L.
    Groppa, L.
    Sarbu, O.
    OSTEOPOROSIS INTERNATIONAL, 2014, 25 : S203 - S203
  • [23] SURVIVAL OF GOUT PATIENTS
    Eliseev, M. S.
    Denisov, I. S.
    Barskova, V. G.
    TERAPEVTICHESKII ARKHIV, 2012, 84 (05) : 45 - 50
  • [24] GOUT IN CHINESE PATIENTS
    FALK, S
    BRONSTEIN, LH
    BERGER, AR
    NEW YORK STATE JOURNAL OF MEDICINE, 1970, 70 (23) : 2909 - +
  • [25] NEPHROLITHIASIS IN PATIENTS WITH GOUT
    YU, TF
    POSTGRADUATE MEDICINE, 1978, 63 (05) : 164 - 170
  • [26] COMORBIDITIES IN PATIENTS WITH GOUT
    Ichikawa, Naomi
    Taniguchi, Atsuo
    Urano, Wako
    Nakajima, Ayako
    Yamanaka, Hisashi
    NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS, 2011, 30 (12): : 1045 - 1050
  • [27] GOUT IN TOGOLESE PATIENTS
    MIJIYAWA, M
    DJAGNIKPO, K
    DAGBOVIE, K
    AGBETRA, A
    REVUE DU RHUMATISME, 1992, 59 (7-8): : 473 - 477
  • [28] APPLICATION OF GOUT DIARY IN HEALTH EDUCATION OF GOUT PATIENTS
    Miao, H.
    Zhang, L.
    Zhang, G.
    Xu, K.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 1363 - 1363
  • [29] REHABILITATION OF PATIENTS WITH GOUT
    Rotaru, L.
    Groppa, L.
    Sarbu, O.
    Agachi, S.
    OSTEOPOROSIS INTERNATIONAL, 2016, 27 : S451 - S451
  • [30] Safety profile of anti-gout agents: an update
    Stamp, Lisa K.
    CURRENT OPINION IN RHEUMATOLOGY, 2014, 26 (02) : 162 - 168